Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/2/18 → 7/1/23 |
Funding
- Merck Sharp and Cohme Corporation: $8,100.00
A Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1654 in Pre-Term and Full-Term Infants
- Rupp, Richard (PI)
Project: Research project